Search Results for: brca1

62 interactions involving BRCA1 - breast cancer 1, early onset found:

Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
TP53 tumor protein p53
  • Cellular Senescence
  • Activation of BH3-only proteins
  • p53-Dependent G1/S DNA damage checkpoint
  • Oncogene Induced Senescence
  • p53-Dependent G1 DNA Damage Response
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Pre-NOTCH Transcription and Translation
  • Stabilization of p53
  • Transcriptional activation of p53 responsive genes
  • Programmed Cell Death
  • Pre-NOTCH Expression and Processing
  • G1/S DNA Damage Checkpoints
  • Intrinsic Pathway for Apoptosis
  • Transcriptional activation of cell cycle inhibitor p21
  • DNA Damage/Telomere Stress Induced Senescence
  • Signaling by NOTCH
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NOXA and translocation to mitochondria
  • Oxidative Stress Induced Senescence
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Activation of PUMA and translocation to mitochondria
  • Cell Cycle Checkpoints
MYC v-myc avian myelocytomatosis viral oncogene homolog
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
RB1 retinoblastoma 1
  • E2F mediated regulation of DNA replication
  • DNA Damage/Telomere Stress Induced Senescence
  • Synthesis of DNA
  • Mitotic Prophase
  • Cellular Senescence
  • G1 Phase
  • Regulation of DNA replication
  • Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes
  • Orc1 removal from chromatin
  • S Phase
  • Cyclin E associated events during G1/S transition
  • Cell Cycle, Mitotic
  • M Phase
  • Orc1 removal from chromatin
  • Cyclin D associated events in G1
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • G1/S Transition
  • Removal of licensing factors from origins
  • Cyclin A:Cdk2-associated events at S phase entry
  • Switching of origins to a post-replicative state
  • Mitotic G1-G1/S phases
  • Condensation of Prophase Chromosomes
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
CCND1 cyclin D1
  • Chromatin organization
  • Signaling by NOTCH
  • Ubiquitin-dependent degradation of Cyclin D
  • G1 Phase
  • S Phase
  • Cell Cycle, Mitotic
  • RMTs methylate histone arginines
  • Ubiquitin-dependent degradation of Cyclin D1
  • Cyclin D associated events in G1
  • Chromatin modifying enzymes
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Expression and Processing
  • Mitotic G1-G1/S phases
  • Arsenic trioxide
CTNNB1 catenin (cadherin-associated protein), beta 1, 88kDa
  • APC truncation mutants have impaired AXIN binding
  • misspliced GSK3beta mutants stabilize beta-catenin
  • T41 mutants of beta-catenin aren't phosphorylated
  • TCF7L2 mutants don't bind CTBP
  • truncated APC mutants destabilize the destruction complex
  • Signaling by Wnt
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • deactivation of the beta-catenin transactivating complex
  • APC truncation mutants are not K63 polyubiquitinated
  • disassembly of the destruction complex and recruitment of AXIN to the membrane
  • S37 mutants of beta-catenin aren't phosphorylated
  • Degradation of beta-catenin by the destruction complex
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • RNF mutants show enhanced WNT signaling and proliferation
  • S33 mutants of beta-catenin aren't phosphorylated
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Innate Immune System
  • truncations of AMER1 destabilize the destruction complex
  • CDO in myogenesis
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Cytosolic sensors of pathogen-associated DNA
  • formation of the beta-catenin:TCF transactivating complex
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • AXIN missense mutants destabilize the destruction complex
  • S45 mutants of beta-catenin aren't phosphorylated
  • repression of WNT target genes
  • beta-catenin independent WNT signaling
  • deletions in the AMER1 gene destabilize the destruction complex
  • Ca2+ pathway
  • Myogenesis
  • AMER1 mutants destabilize the destruction complex
  • TCF dependent signaling in response to WNT
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Signaling by WNT in cancer
  • Urea
AR androgen receptor
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Levonorgestrel
  • Spironolactone
  • Flutamide
  • Oxandrolone
  • Testosterone
  • Nilutamide
  • Fludrocortisone
  • Drostanolone
  • Nandrolone phenpropionate
  • Bicalutamide
  • Fluoxymesterone
  • Drospirenone
  • Danazol
  • Testosterone Propionate
  • Delta1-dihydrotestosterone
  • Boldenone
  • Calusterone
  • Flufenamic Acid
  • Dihydrotestosterone
  • (2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide
  • Methyltrienolone
  • (3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE
  • Cyproterone
  • Methyltestosterone
  • 17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE
  • (2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
  • 2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE
  • (2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
  • 4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile
  • (2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide
  • (2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
  • (R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE
  • (5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE
  • S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE
  • 1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE
  • 4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE
  • 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile
  • 6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE
  • 3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL
  • Nandrolone decanoate
  • Enzalutamide
ATM ATM serine/threonine kinase
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • Fanconi Anemia pathway
  • G2/M Checkpoints
  • Cellular Senescence
  • p53-Dependent G1/S DNA damage checkpoint
  • p53-Dependent G1 DNA Damage Response
  • Regulation of the Fanconi anemia pathway
  • Stabilization of p53
  • p53-Independent DNA Damage Response
  • Homologous recombination repair of replication-independent double-strand breaks
  • p53-Independent G1/S DNA damage checkpoint
  • Double-Strand Break Repair
  • G1/S DNA Damage Checkpoints
  • ATM mediated phosphorylation of repair proteins
  • DNA Damage/Telomere Stress Induced Senescence
  • Meiotic recombination
  • ATM mediated response to DNA double-strand break
  • G2/M DNA damage checkpoint
  • Regulation of HSF1-mediated heat shock response
  • Cellular response to heat stress
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Homologous Recombination Repair
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Cell Cycle Checkpoints
BRCA2 breast cancer 2, early onset
  • Homologous DNA pairing and strand exchange
  • Meiotic recombination
  • Fanconi Anemia pathway
  • Homologous Recombination Repair
  • Homologous recombination repair of replication-independent double-strand breaks
  • Double-Strand Break Repair
  • Presynaptic phase of homologous DNA pairing and strand exchange
DES desmin
  • Striated Muscle Contraction
MLH1 mutL homolog 1
  • Meiotic recombination
  • Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
  • Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
  • Mismatch Repair
SMAD4 SMAD family member 4
  • Loss of Function of TGFBR2 in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • TGF-beta receptor signaling activates SMADs
  • TGFBR1 LBD Mutants in Cancer
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by BMP
  • Transcriptional regulation of pluripotent stem cells
  • Generic Transcription Pathway
  • Signaling by NODAL
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by Activin
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • SMAD4 MH2 Domain Mutants in Cancer
CDK4 cyclin-dependent kinase 4
  • Meiotic recombination
  • Chromatin organization
  • Ubiquitin-dependent degradation of Cyclin D
  • Cellular Senescence
  • G1 Phase
  • Senescence-Associated Secretory Phenotype (SASP)
  • S Phase
  • Oncogene Induced Senescence
  • Cell Cycle, Mitotic
  • Ubiquitin-dependent degradation of Cyclin D1
  • RMTs methylate histone arginines
  • Cyclin D associated events in G1
  • Chromatin modifying enzymes
  • Oxidative Stress Induced Senescence
  • Transcriptional regulation of white adipocyte differentiation
  • Mitotic G1-G1/S phases
COL1A1 collagen, type I, alpha 1
  • Platelet Adhesion to exposed collagen
  • Collagen formation
  • Collagen degradation
  • Anchoring fibril formation
  • Non-integrin membrane-ECM interactions
  • Degradation of the extracellular matrix
  • Assembly of collagen fibrils and other multimeric structures
  • Cell surface interactions at the vascular wall
  • Syndecan interactions
  • Crosslinking of collagen fibrils
  • ECM proteoglycans
  • GPVI-mediated activation cascade
  • Integrin cell surface interactions
  • Collagen biosynthesis and modifying enzymes
  • Platelet activation, signaling and aggregation
  • Scavenging by Class A Receptors
  • Collagenase
ERCC6 excision repair cross-complementation group 6
  • Nucleotide Excision Repair
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • Transcription-coupled NER (TC-NER)
  • RNA Polymerase I Transcription
  • RNA Polymerase I Transcription Initiation
  • RNA Polymerase I Promoter Clearance
  • Formation of transcription-coupled NER (TC-NER) repair complex
  • Dual incision reaction in TC-NER
MSH2 mutS homolog 2
  • Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
  • Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
  • Mismatch Repair
POMGNT1 protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)
PSAP prosaposin
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Sphingolipid metabolism
  • Metabolism of lipids and lipoproteins
  • Glycosphingolipid metabolism
  • Class A/1 (Rhodopsin-like receptors)
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Peptide ligand-binding receptors
  • Response to elevated platelet cytosolic Ca2+
  • Platelet activation, signaling and aggregation
  • Di-Stearoyl-3-Sn-Phosphatidylethanolamine
SETX senataxin
ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase
  • Role of Abl in Robo-Slit signaling
  • CDO in myogenesis
  • Axon guidance
  • Myogenesis
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Factors involved in megakaryocyte development and platelet production
  • Signaling by Robo receptor
  • Regulation of actin dynamics for phagocytic cup formation
  • Innate Immune System
  • Adenosine triphosphate
  • Imatinib
  • Dasatinib
  • N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide
  • Nilotinib
  • Bosutinib
  • 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
  • 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA
  • MYRISTIC ACID
  • 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE
  • 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE
  • 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide
  • Regorafenib
  • Ponatinib
ATR ATR serine/threonine kinase
  • Fanconi Anemia pathway
  • G2/M DNA damage checkpoint
  • G2/M Checkpoints
  • Meiotic synapsis
  • Regulation of HSF1-mediated heat shock response
  • Cellular response to heat stress
  • Regulation of the Fanconi anemia pathway
  • Activation of ATR in response to replication stress
  • Cell Cycle Checkpoints
HSPD1 heat shock 60kDa protein 1 (chaperonin)
  • Mitochondrial protein import
JUP junction plakoglobin
  • Cell junction organization
  • Cell-cell junction organization
  • Signaling by VEGF
  • Adherens junctions interactions
  • VEGFR2 mediated vascular permeability
  • VEGFA-VEGFR2 Pathway
MRE11A MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
  • Meiotic recombination
  • DNA Damage/Telomere Stress Induced Senescence
  • MRN complex relocalizes to nuclear foci
  • Cytosolic sensors of pathogen-associated DNA
  • Cellular Senescence
  • Assembly of the RAD50-MRE11-NBS1 complex at DNA double-strand breaks
  • Homologous Recombination Repair
  • STING mediated induction of host immune responses
  • Homologous recombination repair of replication-independent double-strand breaks
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Double-Strand Break Repair
  • IRF3-mediated induction of type I IFN
  • Innate Immune System
MSH6 mutS homolog 6
  • Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
  • Mismatch Repair
RPGRIP1 retinitis pigmentosa GTPase regulator interacting protein 1
STAT1 signal transducer and activator of transcription 1, 91kDa
  • Signaling by PDGF
  • Signaling by FGFR in disease
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Antiviral mechanism by IFN-stimulated genes
  • Signaling by SCF-KIT
  • Downstream signal transduction
  • Signaling by FGFR1 mutants
  • Signaling by FGFR mutants
  • Signaling by FGFR1 fusion mutants
STAT3 signal transducer and activator of transcription 3 (acute-phase response factor)
  • Signaling by PDGF
  • Signalling by NGF
  • Signaling by FGFR in disease
  • Cellular Senescence
  • Interleukin-6 signaling
  • Senescence-Associated Secretory Phenotype (SASP)
  • Cytokine Signaling in Immune system
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by SCF-KIT
  • Signaling by Interleukins
  • Transcriptional regulation of pluripotent stem cells
  • Downstream signal transduction
  • Signaling by FGFR1 mutants
  • Signalling to STAT3
  • Signaling by FGFR mutants
  • Signaling by FGFR1 fusion mutants
  • POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
  • Signaling by Leptin
  • Growth hormone receptor signaling
USH2A Usher syndrome 2A (autosomal recessive, mild)
AKT1 v-akt murine thymoma viral oncogene homolog 1
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Signaling by FGFR in disease
  • Activation of BH3-only proteins
  • Signaling by Wnt
  • Platelet Aggregation (Plug Formation)
  • Signaling by EGFRvIII in Cancer
  • AKT phosphorylates targets in the cytosol
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • Regulation of beta-cell development
  • PI3K/AKT activation
  • PI-3K cascade
  • RNF mutants show enhanced WNT signaling and proliferation
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Signaling by PDGF
  • Downregulation of ERBB2:ERBB3 signaling
  • DAP12 interactions
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • GAB1 signalosome
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • G-protein beta:gamma signalling
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • Signaling by ERBB4
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • Activation of BAD and translocation to mitochondria
  • Signaling by EGFR
  • GPCR downstream signaling
  • Signaling by VEGF
  • AKT phosphorylates targets in the nucleus
  • Downstream signal transduction
  • Regulation of gene expression in beta cells
  • Signaling by EGFR in Cancer
  • Fc epsilon receptor (FCERI) signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Costimulation by the CD28 family
  • PIP3 activates AKT signaling
  • Translocation of GLUT4 to the plasma membrane
  • deactivation of the beta-catenin transactivating complex
  • VEGFA-VEGFR2 Pathway
  • Metabolism of nitric oxide
  • G beta:gamma signalling through PI3Kgamma
  • PI3K events in ERBB2 signaling
  • VEGFR2 mediated vascular permeability
  • Downstream signaling of activated FGFR
  • Programmed Cell Death
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • eNOS activation and regulation
  • Intrinsic Pathway for Apoptosis
  • Butyrate Response Factor 1 (BRF1) destabilizes mRNA
  • Innate Immune System
  • Signalling by NGF
  • CTLA4 inhibitory signaling
  • AKT-mediated inactivation of FOXO1A
  • Integrin alphaIIb beta3 signaling
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Negative regulation of the PI3K/AKT network
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • eNOS activation
  • TCF dependent signaling in response to WNT
  • KSRP destabilizes mRNA
  • GPVI-mediated activation cascade
  • Signaling by WNT in cancer
  • Adenosine triphosphate
  • Arsenic trioxide
  • Inositol 1,3,4,5-Tetrakisphosphate
  • N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
  • 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
ATF1 activating transcription factor 1
  • CREB phosphorylation
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • CREB phosphorylation
  • Toll Like Receptor TLR6:TLR2 Cascade
  • Activated TLR4 signalling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • MyD88 cascade initiated on plasma membrane
  • Toll Like Receptor 5 (TLR5) Cascade
  • MyD88 dependent cascade initiated on endosome
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • Toll Like Receptor 9 (TLR9) Cascade
  • Innate Immune System
  • Signalling by NGF
  • TRIF-mediated TLR3/TLR4 signaling
  • MAP kinase activation in TLR cascade
  • NGF signalling via TRKA from the plasma membrane
  • MyD88-independent cascade
  • Toll Like Receptor 2 (TLR2) Cascade
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • MAPK targets/ Nuclear events mediated by MAP kinases
  • Nuclear Events (kinase and transcription factor activation)
BRIP1 BRCA1 interacting protein C-terminal helicase 1
  • Homologous DNA pairing and strand exchange
  • Cytosolic iron-sulfur cluster assembly
  • Homologous Recombination Repair
  • Homologous recombination repair of replication-independent double-strand breaks
  • Double-Strand Break Repair
CHEK2 checkpoint kinase 2
CREBBP CREB binding protein
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Metabolism of lipids and lipoproteins
  • Signaling by Wnt
  • Regulation of gene expression by Hypoxia-inducible Factor
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • Pre-NOTCH Transcription and Translation
  • RNF mutants show enhanced WNT signaling and proliferation
  • Signaling by NOTCH1 in Cancer
  • Orphan transporters
  • Chromatin organization
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • Factors involved in megakaryocyte development and platelet production
  • Chromatin modifying enzymes
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Activation of gene expression by SREBF (SREBP)
  • Transcriptional activation of mitochondrial biogenesis
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • PPARA activates gene expression
  • Cellular response to hypoxia
  • Organelle biogenesis and maintenance
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Attenuation phase
  • HATs acetylate histones
  • RORA activates circadian gene expression
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • HSF1-dependent transactivation
  • TRAF3-dependent IRF activation pathway
  • Signaling by NOTCH1
  • Transcriptional regulation of white adipocyte differentiation
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Pre-NOTCH Expression and Processing
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Innate Immune System
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Cytosolic sensors of pathogen-associated DNA
  • Cellular response to heat stress
  • REV-ERBA represses gene expression
  • Mitochondrial biogenesis
  • Notch-HLH transcription pathway
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • NOTCH1 Intracellular Domain Regulates Transcription
  • TCF dependent signaling in response to WNT
  • TRAF6 mediated IRF7 activation
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Signaling by WNT in cancer
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
DCLRE1C DNA cross-link repair 1C
DCN decorin
  • MPS IIIB - Sanfilippo syndrome B
  • Diseases of glycosylation
  • Heparan sulfate/heparin (HS-GAG) metabolism
  • Defective B4GALT7 causes EDS, progeroid type
  • MPS I - Hurler syndrome
  • MPS IX - Natowicz syndrome
  • Chondroitin sulfate/dermatan sulfate metabolism
  • CS/DS degradation
  • Defective SLC26A2 causes chondrodysplasias
  • Glycosaminoglycan metabolism
  • Degradation of the extracellular matrix
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective CHST14 causes EDS, musculocontractural type
  • Defective PAPSS2 causes SEMD-PA
  • MPS IIIA - Sanfilippo syndrome A
  • Myoclonic epilepsy of Lafora
  • ECM proteoglycans
  • Defective CHST6 causes MCDC1
  • Glycogen storage diseases
  • MPS IIID - Sanfilippo syndrome D
  • A tetrasaccharide linker sequence is required for GAG synthesis
  • Chondroitin sulfate biosynthesis
  • MPS IIIC - Sanfilippo syndrome C
  • Diseases associated with glycosaminoglycan metabolism
  • Mucopolysaccharidoses
  • Defective EXT2 causes exostoses 2
  • MPS II - Hunter syndrome
  • Defective B3GAT3 causes JDSSDHD
  • Defective CHST3 causes SEDCJD
  • Defective EXT1 causes exostoses 1, TRPS2 and CHDS
  • MPS IV - Morquio syndrome A
  • Dermatan sulfate biosynthesis
  • MPS IV - Morquio syndrome B
  • Defective CHSY1 causes TPBS
  • MPS VII - Sly syndrome
  • Metabolism of carbohydrates
  • MPS VI - Maroteaux-Lamy syndrome
DYNC1H1 dynein, cytoplasmic 1, heavy chain 1
  • Organelle biogenesis and maintenance
  • Assembly of the primary cilium
  • G2/M Transition
  • Anchoring of the basal body to the plasma membrane
  • Regulation of PLK1 Activity at G2/M Transition
  • Cell Cycle, Mitotic
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Loss of Nlp from mitotic centrosomes
  • MHC class II antigen presentation
  • Centrosome maturation
  • Mitotic G2-G2/M phases
  • Recruitment of mitotic centrosome proteins and complexes
  • Adaptive Immune System
ELK4 ELK4, ETS-domain protein (SRF accessory protein 1)
EP300 E1A binding protein p300
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Metabolism of lipids and lipoproteins
  • Signaling by Wnt
  • NOTCH2 intracellular domain regulates transcription
  • Regulation of gene expression by Hypoxia-inducible Factor
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Signaling by NOTCH2
  • Pre-NOTCH Transcription and Translation
  • RNF mutants show enhanced WNT signaling and proliferation
  • Signaling by NOTCH1 in Cancer
  • Chromatin organization
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • Factors involved in megakaryocyte development and platelet production
  • Chromatin modifying enzymes
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Mitotic G2-G2/M phases
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • PPARA activates gene expression
  • Cellular response to hypoxia
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Attenuation phase
  • G2/M Transition
  • HATs acetylate histones
  • RORA activates circadian gene expression
  • HSF1-dependent transactivation
  • TRAF3-dependent IRF activation pathway
  • Signaling by NOTCH1
  • Transcriptional regulation of white adipocyte differentiation
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Pre-NOTCH Expression and Processing
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Innate Immune System
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Cytosolic sensors of pathogen-associated DNA
  • Cellular response to heat stress
  • REV-ERBA represses gene expression
  • Cell Cycle, Mitotic
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • NOTCH1 Intracellular Domain Regulates Transcription
  • TCF dependent signaling in response to WNT
  • TRAF6 mediated IRF7 activation
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Signaling by WNT in cancer
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • Polo-like kinase mediated events
ETV5 ets variant 5
FAM161A family with sequence similarity 161, member A
FANCA Fanconi anemia, complementation group A
  • Fanconi Anemia pathway
FANCD2 Fanconi anemia, complementation group D2
  • Fanconi Anemia pathway
  • Regulation of the Fanconi anemia pathway
FLI1 Fli-1 proto-oncogene, ETS transcription factor
JAK2 Janus kinase 2
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • Interferon gamma signaling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Toll Like Receptor 5 (TLR5) Cascade
  • Interleukin receptor SHC signaling
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • MyD88 dependent cascade initiated on endosome
  • SOS-mediated signalling
  • Prolactin receptor signaling
  • SHC-mediated signalling
  • TRIF-mediated TLR3/TLR4 signaling
  • ERK1 activation
  • ERK1 activation
  • GPCR downstream signaling
  • Signaling by VEGF
  • Downstream signal transduction
  • Toll Like Receptor 3 (TLR3) Cascade
  • Signalling to RAS
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Frs2-mediated activation
  • Axon guidance
  • IRS-mediated signalling
  • Interleukin-6 signaling
  • VEGFA-VEGFR2 Pathway
  • Activated TLR4 signalling
  • VEGFR2 mediated cell proliferation
  • GRB2 events in ERBB2 signaling
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • NCAM signaling for neurite out-growth
  • RAF/MAP kinase cascade
  • Signalling to p38 via RIT and RIN
  • Innate Immune System
  • Signaling by Insulin receptor
  • Insulin receptor signalling cascade
  • Interferon Signaling
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • SHC-related events
  • RMTs methylate histone arginines
  • Signaling by FGFR
  • ARMS-mediated activation
  • Toll-Like Receptors Cascades
  • Nuclear signaling by ERBB4
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Signaling by GPCR
  • FCERI mediated MAPK activation
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Toll Like Receptor 9 (TLR9) Cascade
  • Signaling by PDGF
  • DAP12 interactions
  • G-protein beta:gamma signalling
  • Chromatin organization
  • GRB2 events in EGFR signaling
  • SHC-related events triggered by IGF1R
  • Factors involved in megakaryocyte development and platelet production
  • Signaling by ERBB4
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • Chromatin modifying enzymes
  • SHC1 events in ERBB4 signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Signaling by EGFR in Cancer
  • Fc epsilon receptor (FCERI) signaling
  • Interleukin-3, 5 and GM-CSF signaling
  • Growth hormone receptor signaling
  • Signaling by Leptin
  • Signalling to ERKs
  • Prolonged ERK activation events
  • ERK activation
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • IGF1R signaling cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • IRS-related events triggered by IGF1R
  • MyD88 cascade initiated on plasma membrane
  • ERK activation
  • G beta:gamma signalling through PI3Kgamma
  • Downstream signaling of activated FGFR
  • Signalling by NGF
  • SOS-mediated signalling
  • MAP kinase activation in TLR cascade
  • SHC-mediated signalling
  • Cytokine Signaling in Immune system
  • NGF signalling via TRKA from the plasma membrane
  • MyD88-independent cascade
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • ERK2 activation
  • SHC1 events in EGFR signaling
  • FRS2-mediated cascade
  • IRS-mediated signalling
  • ERK2 activation
  • Regulation of IFNG signaling
KIF1B kinesin family member 1B
LCK LCK proto-oncogene, Src family tyrosine kinase
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • Nef and signal transduction
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • Regulation of KIT signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • CD28 co-stimulation
  • Host Interactions of HIV factors
  • CD28 dependent PI3K/Akt signaling
  • The role of Nef in HIV-1 replication and disease pathogenesis
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • TCR signaling
  • Downstream signal transduction
  • Signaling by EGFR in Cancer
  • Fc epsilon receptor (FCERI) signaling
  • Interleukin-2 signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • PIP3 activates AKT signaling
  • HIV Infection
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Nef Mediated CD4 Down-regulation
  • Innate Immune System
  • Signalling by NGF
  • Generation of second messenger molecules
  • Translocation of ZAP-70 to Immunological synapse
  • Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
  • CTLA4 inhibitory signaling
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Cytokine Signaling in Immune system
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • CD28 dependent Vav1 pathway
  • PECAM1 interactions
  • Cell surface interactions at the vascular wall
  • Signaling by FGFR
  • PD-1 signaling
  • GPVI-mediated activation cascade
  • Phosphorylation of CD3 and TCR zeta chains
  • Dasatinib
  • {4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid
  • Staurosporine
  • 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
  • (4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • 3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
  • 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE
  • 5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE
  • N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
  • N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
  • N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine
  • Ponatinib
MSH3 mutS homolog 3
  • Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
  • Mismatch Repair
NBN nibrin
  • ATM mediated phosphorylation of repair proteins
  • Meiotic recombination
  • DNA Damage/Telomere Stress Induced Senescence
  • MRN complex relocalizes to nuclear foci
  • ATM mediated response to DNA double-strand break
  • Cellular Senescence
  • Assembly of the RAD50-MRE11-NBS1 complex at DNA double-strand breaks
  • Homologous Recombination Repair
  • Recruitment of repair and signaling proteins to double-strand breaks
  • Homologous recombination repair of replication-independent double-strand breaks
  • Double-Strand Break Repair
ND1 NADH dehydrogenase, subunit 1 (complex I)
  • Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
  • Respiratory electron transport
  • The citric acid (TCA) cycle and respiratory electron transport
NPC2 Niemann-Pick disease, type C2
PEX5 peroxisomal biogenesis factor 5
PRPF3 pre-mRNA processing factor 3
RBBP8 retinoblastoma binding protein 8
  • Meiotic recombination
RUNX1T1 runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
SMAD2 SMAD family member 2
  • Loss of Function of TGFBR2 in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGFBR1 LBD Mutants in Cancer
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Generic Transcription Pathway
  • Signaling by NODAL
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by Activin
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • SMAD4 MH2 Domain Mutants in Cancer
SMC1A structural maintenance of chromosomes 1A
  • Establishment of Sister Chromatid Cohesion
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Splicing
  • Mitotic Prometaphase
  • Mitotic Telophase/Cytokinesis
  • Separation of Sister Chromatids
  • Meiotic synapsis
  • Cohesin Loading onto Chromatin
  • mRNA Splicing - Major Pathway
  • Mitotic Anaphase
  • S Phase
  • M Phase
  • Cell Cycle, Mitotic
  • Resolution of Sister Chromatid Cohesion
  • Mitotic Metaphase and Anaphase
SNRNP200 small nuclear ribonucleoprotein 200kDa (U5)
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Splicing
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
TSEN54 TSEN54 tRNA splicing endonuclease subunit
UBE3A ubiquitin protein ligase E3A
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Class I MHC mediated antigen processing & presentation
  • Adaptive Immune System
VCP valosin containing protein
  • HSF1 activation
  • Hedgehog ligand biogenesis
  • Processing-defective Hh variants abrogate ligand secretion
  • Hh ligand biogenesis disease
  • Signaling by Hedgehog
  • Cellular response to heat stress
XIAP X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • SMAC binds to IAPs
  • SMAC-mediated dissociation of IAP:caspase complexes
  • SMAC-mediated apoptotic response
  • Signaling by Wnt
  • deactivation of the beta-catenin transactivating complex
  • Apoptotic factor-mediated response
  • TCF dependent signaling in response to WNT
  • RNF mutants show enhanced WNT signaling and proliferation
  • Programmed Cell Death
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by WNT in cancer
  • Intrinsic Pathway for Apoptosis
  • 1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide
  • N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE
ZNF423 zinc finger protein 423